Finance

Beta
Lists
QDEL:NASDAQ
Quidelortho Corp
US$14,13
+0,28%
(+0,040) 1D
US$14,13
0,00% (0,00)
After hours
Closed: 12 ມິ.ຖ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QDEL...
Open
US$14,20
High
US$14,52
Low
US$13,84
Mkt. cap
໙໖໓,໕໔ ລ້ານ
Avg. vol.
໒,໑໓ ລ້ານ
Volume
໑,໒໒ ລ້ານ
52-wk high
US$35,58
52-wk low
US$9,92
EPS
US$-17,82
Beta
໐,໗໗
Shares outstanding
໖໘,໑໙ ລ້ານ
No. of employees
໖ ພັນ
Open
US$14,20
High
US$14,52
Low
US$13,84
Mkt. cap
໙໖໓,໕໔ ລ້ານ
Avg. vol.
໒,໑໓ ລ້ານ
Volume
໑,໒໒ ລ້ານ
52-wk high
US$35,58
52-wk low
US$9,92
EPS
US$-17,82
Beta
໐,໗໗
Shares outstanding
໖໘,໑໙ ລ້ານ
No. of employees
໖ ພັນ
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to QDEL in the past 3 months
Hold
Buy
1
Hold
4
Sell
1
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for QDEL in the last 3 months.
Highest
Current US$14,13
US$13,00 (-8,00%)
Average
US$12,13 (-14,15%)
Lowest
US$11,00 (-22,15%)
News stories
From sources across the web
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6,5 ພັນ
Founded1979
Headquartersແຊນ ດີເອໂກ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Last report
5 ພ.ພ. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
US$-0,04 / US$0,36
-111,21%miss
Revenue / Est. (USD)
໖໑໙,໘໐ ລ້ານ / ໖໕໙,໑໘ ລ້ານ
-5,97%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
613,90 ລ້ານ
699,90 ລ້ານ
723,60 ລ້ານ
619,80 ລ້ານ
Cost of goods sold
339,00 ລ້ານ
362,80 ລ້ານ
401,90 ລ້ານ
354,00 ລ້ານ
Cost of revenue
339,00 ລ້ານ
362,80 ລ້ານ
401,90 ລ້ານ
354,00 ລ້ານ
Research and development expenses
45,70 ລ້ານ
41,50 ລ້ານ
45,80 ລ້ານ
44,90 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
178,00 ລ້ານ
186,90 ລ້ານ
194,40 ລ້ານ
199,30 ລ້ານ
Operating expense
279,40 ລ້ານ
290,40 ລ້ານ
292,70 ລ້ານ
291,20 ລ້ານ
Total operating expenses
618,40 ລ້ານ
653,20 ລ້ານ
694,60 ລ້ານ
645,20 ລ້ານ
Operating income
-4,50 ລ້ານ
46,70 ລ້ານ
29,00 ລ້ານ
-25,40 ລ້ານ
Other non operating income
-5,90 ລ້ານ
-1,20 ລ້ານ
3,60 ລ້ານ
-2,00 ລ້ານ
EBT including unusual items
-229,60 ລ້ານ
-756,90 ລ້ານ
-112,40 ລ້ານ
-79,50 ລ້ານ
EBT excluding unusual items
-53,40 ລ້ານ
-300,00 ພັນ
-17,10 ລ້ານ
-73,10 ລ້ານ
Income tax expense
25,80 ລ້ານ
-23,90 ລ້ານ
18,30 ລ້ານ
12,30 ລ້ານ
Effective tax rate
-11,24%
3,16%
-16,28%
-15,47%
Other operating expenses
5,10 ລ້ານ
14,30 ລ້ານ
6,90 ລ້ານ
200,00 ພັນ
Net income
-255,40 ລ້ານ
-733,00 ລ້ານ
-130,70 ລ້ານ
-91,80 ລ້ານ
Net profit margin
-41,60%
-104,73%
-18,06%
-14,81%
Earnings per share
0,12
0,80
0,46
-0,04
Interest and investment income
600,00 ພັນ
500,00 ພັນ
500,00 ພັນ
900,00 ພັນ
Interest expense
-43,60 ລ້ານ
-49,10 ລ້ານ
-52,00 ລ້ານ
-49,00 ລ້ານ
Net interest expenses
-43,00 ລ້ານ
-48,60 ລ້ານ
-51,50 ລ້ານ
-48,10 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
105,80 ລ້ານ
158,80 ລ້ານ
137,90 ລ້ານ
85,50 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more